-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)
02 Feb 2026 22:02 GMT
… ) -- Brodsky & Smith reminds investors of the following investigations. If … Therapeutics will be acquired by GlaxoSmithKline LLC for $58.00 a …
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)
20 Jan 2026 21:20 GMT
… ) -- Brodsky & Smith reminds investors of the following investigations. If … Therapeutics will be acquired by GlaxoSmithKline LLC for $58.00 a …
-
ABL Bio to Embark on U.S. Investor Roadshow
06 Jan 2026 08:34 GMT
… will meet with overseas institutional investors to introduce its bispecific antibody … to strengthen trust with overseas investors who have had limited communication … -B technology transfer agreement with GlaxoSmithKline (GSK) worth 2.141 billion …
-
Governance and investor confidence in Africa: Bridging the trust gap to unlock capital
15 Dec 2025 10:18 GMT
… from inception. Multinationals such GlaxoSmithKline exited Nigeria after 51 years … a comparative context for evaluating investor confidence, governance performance, and … of public sector corruption shape investors’ perceptions. Nigeria, Egypt, Ethiopia, …
-
Stocks to buy: Rajesh Palviya of Axis Securities suggests Motherson, ABB, Glaxo Pharma shares to buy today
12 Dec 2025 05:21 GMT
… across all time frames
Investors should consider buying, … across all time frames.
Investors should consider buying, holding … 100 levels.
3. GlaxoSmithKline Pharmaceuticals Ltd (GLAXO): CMP at ₹ … across all time frames.
Investors should consider buying, holding …
-
Corona Remedies IPO Opens For Subscription, Retail Investors Drive Demand - Should You Apply?
08 Dec 2025 11:30 GMT
Corona Remedies functions within the Indian pharmaceutical market and competes with other companies in the same domain, including specialty pharmaceutical drug companies and generic drug companies. According to the Red Herring Prospectus of the company, a …
-
PSX gains 1,945 points on improved investor participation
10 Nov 2025 12:24 GMT
- Advertisement -
ISLAMABAD, Nov 10 (APP):The Pakistan Stock Exchange (PSX) closed on a positive note on Monday as the benchmark KSE-100 index gained 1,945.50 points, a positive change of 1.22 percent, settling at 61,538.41 against 159,592.90 recorded in …
-
Investors Drive NGX Up by 4.48%, Adding N4.32 Trillion in Weekly Gains
27 Oct 2025 13:03 GMT
… in recent months, reflected investors’ optimism over improving macroeconomic … investors after earlier gains. Notable among the losers were Oando Plc, GlaxoSmithKline … earnings. The combination of improved investor confidence, stable macroeconomic conditions, …
-
Mecure investors ride antibiotic boom after GSK’s exit
14 Oct 2025 00:47 GMT
When GlaxoSmithKline (GSK) exited Nigeria in late … pharmaceutical self-sufficiency
Analysts say investors are responding to Mecure’s … advantage,” one analyst told BusinessDay. “Investors are betting on its ability …
-
PSX falls 483 points, investors book profits
23 Sep 2025 01:29 GMT
… points around midday as optimistic investors bought attractive stocks. However, the … Gas Development Company (OGDC) and GlaxoSmithKline provided some support, it said … , indicating tighter conditions for leveraged investors. With rollover activity in focus …
About
© 1995-2026